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ABSTRACT
The aim of this study was to assess the changes inmuscle fiber conduction velocity (CV), as a sign of fatigue
during knee extensor contraction in patients with chronic obstructive pulmonary disease (COPD) as com-
pared with healthy controls. Eleven male patients (5 with severe and 6 with moderate COPD; age 67 ±
5 years) and 11 age-matched healthy male controls (age 65 ± 4 years) volunteered for the study. CV was
obtained bymultichannel surface electromyography (EMG) from the vastus lateralis (VL) andmedialis (VM)
of the quadricepsmuscle during isometric, 30-second duration knee extension at 70%ofmaximal voluntary
contraction. Thedecline inCV inboth theVL andVMwas steeper in the severeCOPDpatients than inhealthy
controls (for VL: severe COPD vs. controls −0.45 ± 0.07%/s; p < 0.001, and for VM: severe COPD vs. controls
−0.54 ± 0.09%/s, p < 0.001). No difference in CV decline was found between the moderate COPD patients
and the healthy controls. These findings suggest that severe COPDmay impair muscle functions, leading to
greater muscular fatigue, as expressed by CV changes. The results may be due to a greater involvement of
anaerobic metabolism and a shift towards fatigable type II fibers in the muscle composition of the severe
COPD patients.
Abbreviations
6-MWT 6-minute walk test
BMI Body mass index
BODE Body mass index, airflow obstruction, dyspnea and
exercise capacity
CV Muscle fiber conduction velocity
EMG Electromyography
FEV Forced expiratory volume
FEV1 Forced expiratory volume in 1 second
GOLD Global Initiative for COPD
MNF Mean power spectral frequency
VL Vastus lateralis
VM Vastus medialis
Introduction
Skeletal muscle dysfunction is a well-recognized extra-
pulmonary manifestation of chronic obstructive pulmonary
disease (COPD). Intrinsic muscular alterations, such as re-
distribution of fiber type ratio towards type II fibers (1) and
reduction in muscle oxidative capacity (2), seem to be the main
exercise-limiting factors in COPD patients (3), resulting in a
significant reduction in endurance performance (2). The reduc-
tion in endurance capacity has been found to be correlated with
disease stage (4–6). Recent studies have shown that leg muscle
fatigability is strictly connected with daily physical activity and
CONTACT Gennaro Boccia gennaro.boccia@unito.it Motor Science Research Center, School of Exercise & Sport Sciences, SUISM, Department of Medical Sciences,
University of Turin. , Piazza Bernini, , Torino, Italy.
that it predicts mortality, morbidity, and quality of life better
than lung function measures (7).
Many physiological changes occur during fatiguing muscle
contraction, including altered metabolic milieu (such as accu-
mulation of hydrogen ions) (8), changes in muscle fiber con-
duction velocity (CV) (9), and alterations in the number and
firing rate of the recruited motor units (10). The changes in sur-
face electromyography (EMG) signals that occur during pro-
longed muscle contraction has been defined as EMGmanifesta-
tion of fatigue. Decreases in CV and mean power spectral fre-
quency (MNF) are typical EMG trends seen during fatiguing
contraction (11) and they occur before mechanical task failure
(12). Because greater recruitment of type II muscle fibers has
been demonstrated to generate greater EMG manifestations of
fatigue, measured as a higher rate of changes in EMG variables
over time (13,14), multi-channel surface EMG has been pro-
posed as a tool for the non-invasive characterization of mus-
cle fiber composition (15). CV has been shown to be a more
reliable and sensitive index of fatigue than power spectral fre-
quency, which is usually adopted (16, 17). Moreover, the rate of
change inCV is related to the decrease inmuscle fiber pHduring
a sustained contraction (18).
In addition to conventional outcome measures of fatigue,
such as mechanical task failure and decreased force capabil-
ity after sustained contractions (16), monitoring EMG changes
may yield useful insight in muscle fatigability muscle abnormal-
ities in COPD patients. In our previous study we found that CV
©  Taylor & Francis
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changes during fatigue correlate to disease stage and endurance
capacities in mild to very severe COPD patients (6). The aim
of the present study was to investigate whether the changes in
CV, as a sign of fatigue, during knee extensors contraction differ
between patients with moderate and severe COPD, and healthy
controls. We hypothesized that the rate of CV changes would be
greater in the COPD patients than the healthy controls and that
severe stage disease could be related to a steeper decline in CV
than moderate stage disease.
Methods
Participants
Eleven men with a diagnosis of severe (n = 5) and moderate
(n = 6) airflow obstruction were recruited for the study. Diag-
nostic criteria for chronic airflow obstruction were based on
the GOLD document (19), for which the threshold is a post-
bronchodilator ratio of forced expiratory volume in 1 s (FEV1)
to forced vital capacity (FVC) < 0.7. The patients were catego-
rized in GOLD stages according to the severity of airflow limita-
tion: moderate (stage 2, FEV1 50–80% of predicted) and severe
(stage 3, FEV1 30–50% of predicted). Eleven healthy matched-
age males made up the control group. Table 1 presents the char-
acteristics of the two groups.
All participants were clinically stable, without exacerbation
of disease in the 4 weeks prior to the beginning of the study.
Exclusion criteria were: respiratory tract infections; another res-
piratory disorder; major comorbidity (e.g., cardiovascular dis-
eases, diabetes, cancer); lower limb joint diseases. All partici-
pants provided written informed consent before participation
in the experiments. The study was approved by the Ethics Com-
mittee of the Department of Neurological and Movement Sci-
ence, University of Verona, and carried out in accordance with
the Declaration of Helsinki.
Procedure
In this experimental, cross-sectional study, two separate testing
sessions were conducted. During the first session, pulmonary
function and exercise tolerance were evaluated; during the sec-
ond session (3 days later), surface EMG signals were recorded
during isometric knee extensor contractions. Participants were
instructed to refrain from strenuous physical activity during the
24 hours before each experimental session.
First session: FEV1 and FVC were measured according to
the American Thoracic Society/European Respiratory Soci-
ety (ATS/ERS) Task Force methods (20) using a pulmonary
function test instrument (Quark, Cosmed, Rome, Italy). Exer-
cise tolerance was investigated with the 6-minute walk test
(6MWT) according to a standardized protocol (21). Subjects
were instructed to walk on a 30 m shuttle hallway at their own
pace, while attempting to cover as much ground as possible in
the allotted 6 minutes.
Second session: knee extensor isometric peak torque was
measured using an isokinetic dynamometer (Cybex Norm,
Ronkonkoma, NY, USA). Subjects were seated upright on
the dynamometer chair and secured with a seatbelt. First the
subjects were familiarized with the device by performing 10
submaximal isometric contractions at 60 degrees of knee exten-
sion (0 = full extension). Then maximal voluntary contraction
(MVC) was obtained from the knee extensors in order to
calculate the load level that would be used during surface EMG
measurements. The MVC contractions were performed twice,
with 5-minutes rest in-between; the angle of contraction was
60 degrees and the duration was 5 seconds. If the two MVCs
differed by more than 5%, a third MVC was performed. During
the MVC measurements, the subjects received visual feedback
on exerted torque and strong verbal encouragement to reach
the maximum level on each trial.
The highest MVC value was taken to calculate submaximal
loads. Five minutes after the last MVC, the subjects performed
a fatiguing submaximal position task. They were instructed to
maintain a constant knee extension at 60 degrees until voluntary
exhaustion (limited to 30 s), while supporting a load applied by
the dynamometer equivalent to the 70% of MVC. They received
visual feedback on a display about the actual knee angle andwere
instructed to hold the target value of 60 degrees. The task was
considered failed when the limb moved ±5 degrees for more
than 3 seconds. Standardized encouragement to maintain the
limb as stable as possible, was provided by an operator.
EMG recording
EMG signals were recorded from the vastus lateralis (VL) and
vastus medialis (VM) muscles of the dominant leg in a single
differential configuration using linear adhesive electrode arrays
composed of eight electrodes (silver bars, 5 × 1 mm in size,
5 mm inter-electrode distance, OT Bioelettronica, Turin, Italy).
The skin was slightly abraded with abrasive paste and cleaned
with water in accordance with SENIAM recommendations for
skin preparation (22) before placement of the electrode arrays.
Optimal position and orientation of the array was sought for
each muscle by visual inspection of the EMG signals.
The sites with clear muscle fiber action potential propaga-
tion and the main innervation zones were identified using a
dry linear array of 16 electrodes with 5 mm inter-electrode dis-
tance (OT Bioelettronica). The adhesive electrode arrays were
then placed parallel to themuscle fibers and distally with respect
to the innervation zone, where unidirectional propagation of
the motor unit action potentials was detected. To ensure proper
electrode-skin contact, the electrode cavities of the arrays were
filled with 20–30 μL of conductive paste (Spes-Medica, Batti-
paglia, Italy). The electrode arrays were fixed with an extensi-
ble dressing (Fixomull®, Beiersdorf, Hamburg, Germany). The
EMG signals were amplified, sampled at 2048 Hz, bandpass fil-
tered (3-dB bandwidth, 20–450 Hz, 12 dB/oct slope on each
side), and converted to digital data with a 12-bit A/D converter
(EMG-USB, OT Bioelettronica). Samples were visualized dur-
ing acquisition and then stored on a personal computer using
OT BioLab software version 1.8 (OT Bioelettronica,) for further
analysis. On completion of EMG measurement, subcutaneous
tissue layer thickness was measured with an ultrasound scanner
(Acuson P50, 7.5 MHz linear array transducer, Siemens, Ger-
many) in the locationwhere the adhesive arrayswere positioned.
The EMG signals were visually inspected to select the best
channels for estimating variables. TheMNF andCV of the EMG
signals were computed off-line with numerical algorithms (12)
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ità
 de
gli
 St
ud
i d
i V
ero
na
], 
[g
en
na
ro
 bo
cc
ia]
 at
 10
:32
 23
 M
arc
h 2
01
6 
COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
Table . Means (± standard deviation) of groups’ characteristics, lung function, and exercise tolerance values are reported.
Participants N° AGE (years) BMI (kg/m) FEV (% of predicted) FEV/FVC (% of predicted) BODE MWT (m)
Healthy   ±  . ± . . ± .  ±  . ± . .  ± 
COPD   ±  . ± . . ± .  ±  . ± .  ± 
Moderate   ±  . ± . . ± .∗∗  ± ∗∗ . ± .∗∗  ± ∗∗
Severe   ±  . ± . . ± .∗∗§§  ± ∗∗§§ . ± .∗∗§§  ± ∗∗§§
-minute walk test (-MWT); Body mass index (BMI); Body mass index, airﬂow Obstruction, Dyspnea and Exercise capacity (BODE); Forced vital capacity (FVC); Forced
expiratory volume in  second (FEV); Statistically signiﬁcant diﬀerences of severe COPD compared to healthy subjects are reported:∗∗p< ., and compared to moderate COPD are reported as §§p< ..
using non-overlapping signal epochs of 0.5 seconds. The average
CV was estimated among all the accepted channels and com-
puted as e/d, where e is the inter-electrode distance and d is the
delay time between the signals obtained from the two double
differential arrays spaced 5 mm apart. The correlation coeffi-
cient between the two adjacent double differential signals was
calculated; if the correlation coefficient was < 0.8, the recorded
signals were excluded from the analysis. MNF estimates were
averaged from the accepted channels.
Statistical analysis
Linear regression analysis was applied to the time course of the
EMG variables since it has been demonstrated to be the best
model to fit EMG data acquired during fatiguing contractions
(11). The initial value of each EMG variable was calculated as
the intercept of the regression line at time= 0 s, which is the first
instant of muscle contraction where the exerted torque reaches
the target level. The rate of change in the EMG variable was cal-
culated as the percentage ratio between the change in EMG esti-
mate in one second and the initial value (expressed as %/s). The
rate of changes in EMG estimates were used as indices of EMG
manifestations of fatigue.
The COPD group was subdivided into a severe (n = 5) and
a moderate (n = 6) COPD group (Table 1). Two-way ANOVA
(muscle × groups) followed by a t-test with Bonferroni cor-
rection were used to determine EMG differences between the
3 groups (severe COPD, moderate COPD, and healthy con-
trols). FEV1, FEV1/FVC, BODE index, and 6MWT were ana-
lyzed using one-way ANOVA. The difference in subcutaneous
tissue thickness between the whole COPD and healthy groups
was analyzed using a t-test. The threshold for statistical signifi-
cance was set at p < 0.05.
Results
All CV estimateswere found to bewithin the physiological range
(3.5 m/s to 5.7 m/s) and all EMG signals chosen for estimating
the variables showed a high correlation coefficient (0.85 ± 0.5).
Subcutaneous tissue thickness was greater in the COPD patients
than in the healthy controls in both the VL (5.3 ± 1.2 mm in
COPD patients vs. 3.5 ± 0.8 mm in controls; p = 0.05) and VM
(5.9 ± 1.4 mm in COPD patients vs. 4.7 ± 1.1 mm in controls;
p= 0.05). Due to this difference, the initial CV andMNF values
could not be compared between the groups because the absolute
value of these variables are strongly affected by subcutaneous tis-
sue thickness (23).
Rate of change in CV
No significant muscle × group interactions were found (p =
0.542) for the rate of change in CV. There was a main effect for
group (p < 0.001) but not for muscle (p = 0.390). The decline
in CV in the VL was steeper in the severe than in the moderate
COPD patients (severe vs. moderate COPD −0.47 ± 0.08%/s,
confidence interval [CI] 95% −0.69 to −0.25, p < 0.001, η2 =
0.701) and the healthy controls (severe COPDvs. controls−0.45
± 0.07%/s, CI 95% −0.64 to −0.25, p < 0.001, η2 = 0.685)
(Fig. 1). Similarly, the decline inCV in theVMwas steeper in the
severe than in the moderate COPD patients (severe vs. moder-
ate COPD−0.58± 0.10%/s, CI 95%−0.86 to−0.31, p< 0.001,
η2 = 0.608) and the healthy controls (severe COPD vs. con-
trols −0.54 ± 0.09%/s, CI 95% −0.79 to −0.30, p < 0.001, η2
= 0.583). No significant difference in the rate of change in CV
was found between the patients with moderate COPD and the
healthy controls (Fig. 1).
Rate of change in MNF
No significant muscle × group interactions were found (p =
0.862) for the rate of change inMNF. There was amain effect for
group (p= 0.010) but not for muscle (p= 0.666). The decline in
MNF in the VL was steeper in the severe than in the moderate
COPD patients (severe vs. moderate COPD −0.52 ± 0.19%/s,
CI 95% −1.02 to −0.17, p = 0.041, η2 = 0.359) and the healthy
controls (severe COPD vs. controls −0.53 ± 0.17%/s, CI 95%
−0.97 to−0.08, p = 0.018, η2 = 0.385). Similarly, the decline in
MNF in the VM was steeper in the severe COPD patients than
the healthy controls (severeCOPDvs. controls−0.60± 0.20%/s,
CI 95% −1.14 to −0.06, p = 0.026, η2 = 0.342). No significant
difference in the rate of change in MNF was found between the
severe and the moderate COPD patients (severe vs. moderate
COPD−0.60± 0.23%/s, CI 95%−1.20 to 0.05, p= 0.053, η2 =
0.265) or between the moderate COPD patients and the healthy
controls (Fig. 2).
Discussion
This is the first study that used CV to compare muscle qualities
of COPD patients with those of age-matched healthy controls.
The main finding of this study is that during fatiguing exer-
cises of the legs, EMG fatigue appears earlier in severe COPD
patients than in healthy controls. There was no difference in the
pattern of EMG fatigue between the moderate COPD patients
and controls (Fig. 1). A greater proportion of type II muscle
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Figure . Scatter dot plot (and median) of rates of change (%/s) in muscle ﬁber conduction velocity (CV) during isometric contraction at % of maximal voluntary con-
traction of the vastus lateralis (left) and medialis (right) muscles. Statistically signiﬁcant diﬀerences are reported: ∗∗∗p< ..
fibers has been demonstrated to generate greater EMG mani-
festations of fatigue, measured as a greater decrease in CV over
time (13,14,24). These can be explained by the fact that type II
muscle fibers rely on glycolytic processes and are more prone to
fatigue than type I fibers (25), which relying on oxidative pro-
cesses. Our results suggest that there may be a shift towards type
II fibers in the muscles of severe COPD patients. These findings
are supported by histochemical studies that showed a decrease
in type I fibers, accompanied by an increase in type IIx fibers, in
the muscles of severe COPD patients (1).
Protocols based on CV estimates, which were similar to the
one we used, have been proposed as a potential tool for the
non-invasive characterization of muscle fiber composition (15).
Except a shift towardsmore glycolytic fibers, there are also other
possible changes that may contribute to greater fatigability in
patients with severe COPD (2). These include: a decreased cap-
illary density, a reduction in capillary-muscle fiber contacts, and
lower levels of oxidative enzyme activity (2). During exercise at
the same absolute work rate, the blood pH decreases to lower
levels in COPD patients than age-matched controls (26, 27).
This phenomenonmight be related to the greater CV reduction,
identified in our study, in COPD patients compared to healthy
controls.
Previous studies have reported that muscle dysfunction is
present even in the early stages of COPD, indeed endurance
capacity is impaired also in patients with mild to moderate
disease (28, 29). The present results do not corroborate these
findings, since augmented electromyographic fatigue was found
only in patients with severe but not moderate COPD. Possibly,
not onlymuscles, but alsomore general factors would impair the
endurance in the early stages of COPD.
Methodological approach
We adopted a protocol based on localized contractions (only
a knee extension) in order to minimize the impact of mus-
cle contractions on cardiopulmonary function (30). It seems
that patients with severe ventilatory limitations (as those
included in the present study) are able to keep a localized
isometric contraction long enough in time to develop muscle
fatigue.
Endurance performance of the quadriceps muscle has been
lower in COPD patients than in healthy subjects, independent
of the type of task and measurement technique (16). Although
dynamic contractions may yield more information about fiber
distribution than isometric contractions (31), we selected iso-
metric contraction because it was the easiest to use. Moreover,
we set a high contraction level to obtain fatigue quickly and
to exclude motor unit rotation (i.e., motor units recruitment/
de-recruitment) during the course of contraction, which can
bias CV estimates (32). Another value of using high force lev-
els is that fatigue will probably be less dependent on the central
influence (changes in central activation); so the peripheral (mus-
cular) fatigue will be expressed clearer (33).
In this study, with a high contraction level of 70% of MVC,
the CV variable appeared to be more sensitive than the MNF in
detecting differences in fatigue between the COPD patients and
Figure . Scatter dot plot (and median) of rates of change (%/s) in mean power frequency (MNF) during isometric contraction at % of maximal voluntary contraction of
the vastus lateralis (left) and medialis (right) muscles. Statistically signiﬁcant diﬀerences are reported: ∗p< ..
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healthy subjects. Comparable results were found in our previ-
ous study (6). In contrast, two earlier studies, which only applied
MNF, found differences in EMG fatigue betweenCOPDpatients
and healthy controls only at low forces and not at higher forces
(10% MVC versus 60% MVC) (30, 34). MNF is simpler to use
because it only needs one-channel bipolar EMG whereas CV is
obtained from multi-channel EMG (17). When fatigue proto-
cols are used at high force levels, monitoring of CV seems more
reliable and sensitive then spectral variables (such as MNF),
because the later are strongly affected by a number of confound-
ing factors which less bias CV estimates (17).
Analysis of histochemical alterations induced by COPD have
largely come from investigations on the VL muscle because it is
readily accessible for biopsy and this has often been used to rep-
resent thewhole quadricepsmuscle.However, theVL is only one
component of the quadriceps, and we found it useful to expand
our knowledge and compare two components of the quadriceps,
the VL and VM.
In healthy young and elderly men, the VL and VM differ in
both histochemical (35) and EMG characteristics (36, 37). Nev-
ertheless, in COPD patients, we found the same trends in the
EMG indices of fatigue in both muscles.
Limitations
The main limitation of this study was the small sample size,
which reduced the power of the results and the possibility to gen-
eralize our findings to the COPD population as a whole. More-
over, our sample was not balanced for the full spectrum of dis-
ease severity since we did not include patients with mild or very
severe COPD. The isometric contraction we used for assessing
fatigability is a highly reproducible task and is easy to perform;
however, it is far unlike real-life movement or every day physical
demands. Finally, because the results pertain to the VL and VM
muscles, they cannot be extrapolated to othermuscle groups that
may have different usage and fatigue properties.
Conclusions
The rate of change in CV, as a sign of fatigue, during fatiguing
quadriceps contraction was greater in the (male) patients with
severe COPD than in the healthy, age-matched controls. No dif-
ferences were found between the patients with moderate COPD
and healthy controls. These findings may reflect a higher grade
of reduction in muscle oxidative capacity, with a shift towards
type II muscle fibers in severe COPD patients. Monitoring the
rate of changes in CV during prolonged contractions may yield
new insights in diseases compromising muscle qualities, such as
COPD.
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